Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
diffuse splenic calcifications in systemic lupus erythematosus a case based review
Original title: “Diffuse splenic calcifications in systemic lupus erythematosus: a case-based review.”
lupus enteritis with concomitant genitourinary involvement as the initial presentation of juvenile onset systemic lupus erythematosus
Original title: “Lupus Enteritis With Concomitant Genitourinary Involvement as the Initial Presentation of Juvenile-Onset Systemic Lupus Erythematosus.”
Greater flexibility for people with systemic lupus erythematosus
Original title: “Saphnelo approved in the US for subcutaneous self‑administration”
systematic review of culture confirmed septic pericarditis in systemic lupus erythematosus with an index case
Original title: “Systematic review of culture-confirmed septic pericarditis in systemic lupus erythematosus with an index case.”
belimumab use in pediatric onset systemic lupus erythematosus a status report in france from a retrospective multicentre descriptive study
Original title: “Belimumab use in pediatric-onset systemic lupus erythematosus: a status report in France from a retrospective multicentre descriptive study.”
Leading Beeline Medicines’ pipeline is afimetoran, which is in Phase 2 development for systemic lupus erythematosus with data expected later this year.
Original title: “BMS makes a Beeline, bringing 5 assets to biotech's $300M precision immunology debut”
tofacitinib versus baff inhibitor in mild to moderate systemic lupus erythematosus a real world study based on cstar cohort
Original title: “Tofacitinib versus BAFF inhibitor in mild to moderate systemic lupus erythematosus: a real-world study based on CSTAR cohort.”
delayed recognition of systemic lupus erythematosus presenting with visceral muscle dysmotility and chronic mucus bloody enteropathy a case report
Original title: “Delayed Recognition of Systemic Lupus Erythematosus Presenting With Visceral Muscle Dysmotility and Chronic Mucus-Bloody Enteropathy: A Case Report.”
bullous systemic lupus erythematosus in a southeast asian cohort high systemic association driving systemic therapy
Original title: “Bullous Systemic Lupus Erythematosus in a Southeast Asian Cohort: High Systemic Association Driving Systemic Therapy.”
pulmonary involvement in anca associated vasculitis overlapping with long standing systemic lupus erythematosus
Original title: “Pulmonary Involvement in ANCA-associated Vasculitis Overlapping with Long-standing Systemic Lupus Erythematosus.”
chronic ascites as the initial presentation of systemic lupus erythematosus in a 37 year old syrian female patient a case report
Original title: “Chronic ascites as the initial presentation of systemic lupus erythematosus in a 37-year-old Syrian female patient: a case report.”
case report the unusual association of kartagener s syndrome and systemic lupus erythematosus
Original title: “Case report: the unusual association of Kartagener's syndrome and systemic lupus erythematosus.”
patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab interim analysis from the ongoing multicentre observational reveal study
Original title: “Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study.”